Home › Funds › Trails Edge Capital Partners, LP › KLRA
Trails Edge Capital Partners, LP position in KLRA
KAILERA THERAPEUTICS INC · Health Care
Trails Edge Capital Partners, LP reported holding 984,786 shares of KLRA (KAILERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$21.7M, representing 3.44% of its reported portfolio and ranking #14 among its reported holdings. Trails Edge Capital Partners, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Trails Edge Capital Partners, LP's KLRA position evolved
Trails Edge Capital Partners, LP first disclosed a stake in KLRA in Q2 2026 at 984,786 shares (US$21.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 984.79K | $21.69M | New |
About KLRA and 13F data
KLRA (KAILERA THERAPEUTICS INC) is a Health Care company. 110 other funds we track also report a position in KLRA — the largest reported positions include BAIN CAPITAL INVESTORS LLC (US$578.4M), Bain Capital Life Sciences Investors, LLC (US$497.5M), RTW INVESTMENTS, LP (US$237.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KLRA
- BAIN CAPITAL INVESTORS LLC 26.26M sh · $578.41M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 22.58M sh · $497.51M · Q2 2026
- RTW INVESTMENTS, LP 10.78M sh · $237.41M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 5.17M sh · $113.92M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.46M sh · $54.09M · Q2 2026
- Siren, L.L.C. 2.21M sh · $48.78M · Q2 2026
- Farallon Capital Management 1.10M sh · $24.23M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 1.10M sh · $24.23M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.10M sh · $24.23M · Q2 2026
- Cormorant Asset Management, LP 550.00K sh · $12.12M · Q2 2026
- Catalio Capital Management, LP 468.75K sh · $10.33M · Q2 2026
- a16z Capital Management, L.L.C. 140.00K sh · $3.08M · Q2 2026
More on Trails Edge Capital Partners, LP
FAQ
How long has Trails Edge Capital Partners, LP held KLRA?
Trails Edge Capital Partners, LP has disclosed KLRA holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Trails Edge Capital Partners, LP's current position in KLRA?
As of Q2 2026, Trails Edge Capital Partners, LP holds 984.79K shares of KLRA (KAILERA THERAPEUTICS INC), valued at $21.69M, representing 3.44% of its reported portfolio and ranking #14.
Has Trails Edge Capital Partners, LP been buying or selling KLRA?
In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP newly opened its position in KLRA.
Which other funds hold KLRA?
Other major institutional holders of KLRA include BAIN CAPITAL INVESTORS LLC, Bain Capital Life Sciences Investors, LLC, RTW INVESTMENTS, LP, among 110 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.